+34%

est. 2Y upside i

Series A

Medicinal Chemistry powered by Machine Learning

Rank

#1804

Sector

TechBio

Est. Liquidity

~4Y

Data Quality

Data: Low

PostEra offers a moderate equity upside potential (34% expected) over 2 years, with significant downside risk from high incumbent competition and a stale valuation.

Last updated: July 3, 2026

Bull (15%)+115%

Bull case: PostEra maintains its 7.5x revenue multiple due to expanded Pfizer partnership and potential IPO window, yielding $163.8M exit value. Common stock returns 115% on $64M entry common value.

Base (40%)+47%

Base case: Multiple compresses to 5.5x (mid of public comp range) as growth normalizes, exit value $120.1M. Common stock returns 47%.

Bear (45%)-4%

Bear case: Multiple falls to 4x (below comp range) due to intense incumbent threat from Big Tech and public peers, exit value $87.4M. Common stock declines 4%.

Est. time to liquidity~4.0 years

Preference Stack Risk

high

Funding Intensity

2890%

Total funding of $26M represents 29% of $90M valuation, so preferred stock has a 1x liquidation preference that must be satisfied before common stock receives value.

Dilution Risk

low

Company is profitable with $7.1M revenue and strong partnership cash flows, making a near-term fundraise unlikely.

Secondary Liquidity

none

No secondary market activity reported; employees must wait for an IPO or acquisition for liquidity.

Business — 1 role

Software Engineering — 1 role

View all 2 open roles at PostEra →

Last updated: March 10, 2026

Questions to Ask at the Interview

Strategic questions based on PostEra's data — designed to show you've done your homework.

  • 1

    “How does PostEra's Proton platform differentiate from AI drug discovery tools from Big Tech like Google DeepMind?”

  • 2

    “With a hybrid revenue model combining milestones and royalties, what is the path to predictable recurring revenue?”

  • 3

    “Given the preference stack and 409A valuation, what is the likely strike price and dilution for new hires?”

Community

Valuation Sentiment

Our model estimates +34% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.